Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jiashuai He
Observed names:
JIASHUAI HE,
Jia-Shuai He,
Jia-shuai He
Institutions:
North China University of Science and Technology,
University of Jinan,
First Affiliated Hospital of Jinan University
Observed institutions:
North China University of Science and Technology,
University of Jinan,
First Affiliated Hospital of Jinan University
ORCID:
0000-0003-0840-9348
Observed ORCID:
0000-0003-0840-9348
OpenAlex ID:
A5082665753
CYP1B1 inhibits ferroptosis and induces anti-PD-1 resistance by degrading ACSL4 in colorectal cancer
2023
·
Congcong Chen
, Yabing Yang
, et al.
·
Cell Death and Disease
·
141
PDF
The Application of and Strategy for Gold Nanoparticles in Cancer Immunotherapy
2021
·
Jia-shuai He
, Shi-jin Liu
, et al.
·
Frontiers in Pharmacology
·
82
PDF
Targeting PLK1-CBX8-GPX4 axis overcomes BRAF/EGFR inhibitor resistance in BRAFV600E colorectal cancer via ferroptosis
2025
·
Zhan Zhao
, Jiashuai He
, et al.
·
Nature Communications
·
42
PDF
Tumor neoantigens: Novel strategies for application of cancer immunotherapy
2023
·
HANYANG GUAN
, YUE WU
, et al.
·
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
·
37
PDF
Targeting SLC7A11 with sorafenib sensitizes stereotactic body radiotherapy in colorectal cancer liver metastasis
2025
·
Jiashuai He
, Yiran Zhang
, et al.
·
Drug Resistance Updates
·
36
Targeting LAYN inhibits colorectal cancer metastasis and tumor-associated macrophage infiltration induced by hyaluronan oligosaccharides
2023
·
Yabing Yang
, Zuyang Chen
, et al.
·
Matrix Biology
·
25
Targeting FAPα-positive lymph node metastatic tumor cells suppresses colorectal cancer metastasis
2023
·
Shuran Fan
, Ming Qi
, et al.
·
Acta Pharmaceutica Sinica B
·
15
Endostatin induces normalization of blood vessels in colorectal cancer and promotes infiltration of CD8+ T cells to improve anti-PD-L1 immunotherapy
2022
·
Xiao-Dong Chu
, Hui Bao
, et al.
·
Frontiers in Immunology
·
12
PDF
Identification of a Novel Ferroptosis-Related Gene Prediction Model for Clinical Prognosis and Immunotherapy of Colorectal Cancer
2021
·
Ya-bing Yang
, Jia-xin Zhou
, et al.
·
Disease Markers
·
12
PDF
Protective role of seleno-amino acid against IBD via ferroptosis inhibition in enteral nutrition therapy
2024
·
Shuchen Huangfu
, Jie Zheng
, et al.
·
iScience
·
10
PADI1 and Its Co-Expressed Gene Signature Unveil Colorectal Cancer Prognosis and Immunotherapy Efficacy
2022
·
Yi-ran Zhang
, Lei Zhang
, et al.
·
Journal of Oncology
·
7
PDF
Editorial: Dual role of inflammatory mediators in cancer immunotherapy
2023
·
Xiaoli Wang
, Jiashuai He
, et al.
·
Frontiers in Immunology
·
4
PDF
Gamma Knife stereotactic radiotherapy combined with tislelizumab as later-line therapy in pMMR/MSS/MSI-L metastatic colorectal cancer: a phase II trial analysis
2025
·
Yiran Zhang
, Hanyang Guan
, et al.
·
eLife
·
2
PDF
Multi-mechanism crystal plasticity simulation and experimental study for uniaxial tensile deformation of 7Mn1Al Medium-Mn steel
2025
·
Mingming Wang
, Jiashuai He
, et al.
·
Journal of Materials Research and Technology
·
1
Gamma Knife stereotactic radiotherapy combined with tislelizumab as later-line therapy in pMMR/MSS/MSI-L metastatic colorectal cancer: a phase II trial analysis
2025
·
Yiran Zhang
, Hanyang Guan
, et al.
·
eLife
Author response: Gamma Knife stereotactic radiotherapy combined with tislelizumab as later-line therapy in pMMR/MSS/MSI-L metastatic colorectal cancer: a phase II trial analysis
2025
·
Yiran Zhang
, Hanyang Guan
, et al.
·
eLife
Author response: Gamma Knife Stereotactic radiotherapy combined with tislelizumab as later-line therapy in hpMMR/MSS/MSI-L metastatic colorectal cancer: A Phase II Trial Analysis
2025
·
Yiran Zhang
, Hanyang Guan
, et al.
·
eLife
Gamma Knife Stereotactic radiotherapy combined with tislelizumab as later-line therapy in hpMMR/MSS/MSI-L metastatic colorectal cancer: A Phase II Trial Analysis
2025
·
Yiran Zhang
, Hanyang Guan
, et al.
·
eLife
Characterization of a novel cell line established from mice gastrointestinal stromal model by chemical induction
2025
·
Zhan Zhao
, Shenghui Qiu
, et al.
·
Translational Oncology
Gamma Knife Stereotactic radiotherapy combined with tislelizumab as later-line therapy in pMMR/MSS/MSI-L metastatic colorectal cancer: A Phase II Trial Analysis
2025
·
Yiran Zhang
, Hanyang Guan
, et al.
·
eLife
PDF
Author response: Gamma Knife Stereotactic radiotherapy combined with tislelizumab as later-line therapy in pMMR/MSS/MSI-L metastatic colorectal cancer: A Phase II Trial Analysis
2025
·
Yiran Zhang
, Hanyang Guan
, et al.
·
eLife
PDF
Show more works
View as search
Works count:
21
Citation count:
426
H-index:
10
I10-index:
10
Year
Topic
Type